Microglia’s Surprising Role in Alzheimer’s Plaque Formation

For decades, microglia – the brain’s resident immune cells – have been considered potential defenders against Alzheimer’s disease, tasked with clearing the toxic amyloid plaques that characterize the condition. However, groundbreaking research published in PNAS[1] challenges this long-held belief, revealing that microglia can actively promote plaque formation, particularly in the early stages of the disease.

Challenging the Conventional Wisdom

Alzheimer’s disease, affecting nearly 55 million people globally, is defined by the accumulation of amyloid plaques in the brain, leading to neuronal death and progressive dementia. Traditionally, the focus has been on stimulating microglia to remove these plaques. But researchers at the VIB-KU Leuven Center for Neuroscience have discovered a surprising duality in microglial function. “Most studies suggest that microglia are there to clean up the brain and remove the amyloid plaques. What we discovered is that actually they’re part of the problem. They generate plaques,” explains Professor Joost Schymkowitz, co-senior author of the study [1].

How Microglia Contribute to Plaque Formation

The research team found that microglia can remodel soluble amyloid-beta (Aβ42) into extracellular fibrils with potent seeding activity. Seeding is a critical process in Alzheimer’s disease, where one aggregate triggers the formation of numerous modern ones, accelerating plaque buildup. Essentially, microglia aren’t just failing to clear the plaques. they are actively creating them.

“It was thought that plaques aggregate by themselves. And the microglia, by trying to deal with the problem, amplify it,” adds Prof. Schymkowitz [1].

A More Realistic Model of Alzheimer’s

The study’s findings suggest that many plaques in Alzheimer’s brains may originate through cellular processes rather than spontaneous aggregation. The amyloid fibrils generated by microglia more closely resemble those found in the brains of Alzheimer’s patients than those formed in traditional laboratory settings. This allows for a more accurate model for studying the disease.

“For a long time, we’ve studied amyloid plaques in the lab, where they form spontaneously in small vials. However when researchers began solving amyloid structures from patients, it became clear that these structures differ markedly from those formed in laboratory conditions,” explains Prof. Schymkowitz [1].

Implications for Alzheimer’s Therapies

This discovery has significant implications for the development of Alzheimer’s therapies. Current strategies often aim to stimulate microglia to clear amyloid plaques. However, the new research suggests that, depending on the stage of the disease, microglia may too contribute to plaque formation. This insight could influence how these therapies are designed and targeted.

Ongoing Research at VIB-KU Leuven

The VIB-KU Leuven Center for Neuroscience is actively investigating the underlying mechanisms of Alzheimer’s and Parkinson’s disease, utilizing advanced techniques like single-cell, genome-wide transcription profiling to understand the complex cellular changes involved [2]. Researchers are also exploring the role of other brain cells, such as astrocytes, in the development of Alzheimer’s pathology [3].

Key Takeaways

• Microglia, traditionally seen as plaque clearers, can actively contribute to plaque formation in Alzheimer’s disease.
• Microglia remodel amyloid-beta into fibrils that promote plaque seeding.
• The findings suggest a need to re-evaluate current therapeutic strategies targeting microglia.
• A more realistic model of plaque formation is now available for research.

This research, supported by organizations including the Research Foundation Flanders and the Alzheimer’s Association USA [4], represents a crucial step forward in understanding the complexities of Alzheimer’s disease and developing more effective treatments.